Association of Dapagliflozin vs Placebo with Individual Kansas City Cardiomyopathy Questionnaire Components in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial
Alexander Peikert, Alvin Chandra, Mikhail N. Kosiborod, Brian L. Claggett, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Silvio E. Inzucchi, Felipe A. Martinez, Rudolf A. De Boer, Adrian F. Hernandez, Sanjiv J. Shah, Stefan P. Janssens, Jan Bělohlávek, C. Jan Willem Borleffs, Dan Dobreanu, Anna Maria Langkilde, Olof Bengtsson, Magnus Petersson, John J.V. McMurrayScott D. Solomon*, Muthiah Vaduganathan
Dive into the research topics of 'Association of Dapagliflozin vs Placebo with Individual Kansas City Cardiomyopathy Questionnaire Components in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial'. Together they form a unique fingerprint.